Factores impulsores y métodos de puntuación para mejorar el control de la enfermedad renal crónica en la atención primaria. Una propuesta peruana de modelo operativo
| datacite.rights | http://purl.org/coar/access_right/c_abf2 | |
| dc.contributor.author | Herrera-Añazco, Percy | |
| dc.contributor.author | Vallejos, Augusto | |
| dc.contributor.author | Depine, Santos | |
| dc.contributor.author | Diaz-Arocutipa, Carlos | |
| dc.contributor.author | Kikushima-Alcántara, Pedro | |
| dc.contributor.author | Benites-Zapata, Vicente | |
| dc.date.accessioned | 2025-11-04T15:06:07Z | |
| dc.date.available | 2025-11-04T15:06:07Z | |
| dc.date.issued | 2005 | |
| dc.description.abstract | Para la implementación de la vía de abordaje HEARTS para el manejo del paciente con enfermedad renal crónica (ERC), de la iniciativa HEARTS, es necesaria la incorporación de impulsores del control de la enfermedad basados en la mejor evidencia disponible, así como de sus respectivos índices de madurez y desempeño. Para esto, se creó un grupo interdisciplinario encargado de seleccionar los factores impulsores clave del control de la ERC, basados en la evidencia, y que diseñó un método de puntuación integral para dar seguimiento a su implementación en los centros de primer nivel de atención. Se identificaron siete impulsores, que se agruparon según los componentes del abordaje de la enfermedad: dos impulsores orientados al diagnóstico, dos al tratamiento, y uno a cada uno de los siguientes dominios: continuidad de la atención y seguimiento, sistema de prestaciones y sistema de evaluación del desempeño. Estos impulsores guiarán el proceso de mejora de la calidad con el objetivo de alcanzar los objetivos de control de la ERC a nivel poblacional. | spa |
| dc.description.abstract | For the implementation of the HEARTS Approach Pathway for managing patients with chronic kidney disease (CKD) within the HEARTS initiative, the incorporation of disease control drivers based on the best available evidence is necessary, along with their respective maturity and performance indices. To this end, an interdisciplinary group was established to select the key evidence-based drivers of CKD control and to design a comprehensive scoring method to monitor its implementation in primary care centers. Seven drivers were identified and grouped according to the components of disease management: two drivers focused on diagnosis, two on treatment, and one each in the following domains: continuity of care and follow-up, service delivery system, and performance evaluation system. These drivers will guide the quality improvement process with the objective of achieving CKD control targets at the population level. | eng |
| dc.format.mimetype | ||
| dc.identifier.citation | Herrera-Añazco P, Vallejos A, Depine S, Diaz-Arocutipa C, Kikushima-Alcántara P, Benites- Zapata V. Factores impulsores y métodos de puntuación para mejorar el control de la enfermedad renal crónica en la atención primaria. Una propuesta peruana de modelo | |
| dc.identifier.doi | https://doi.org/10.35663/amp.2025.423.3709 | |
| dc.identifier.issn | 1728-5917 (Electrónico) | |
| dc.identifier.issn | ISSN: 1018-8800 (Impreso) | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12442/17082 | |
| dc.identifier.url | https://amp.cmp.org.pe/index.php/AMP/article/view/3709/2032 | |
| dc.language.iso | spa | |
| dc.publisher | Colegio Médico del Perú | spa |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess | |
| dc.source | Acta Med Peru. | spa |
| dc.source | Acta Médica Peruana | spa |
| dc.source | Vol. 42 No. 3 Año 2025 | spa |
| dc.subject | Enfermedad Renal Crónica | spa |
| dc.subject | Calidad de la Atención de Salud | spa |
| dc.subject | ndicadores de Calidad de la Atención de Salud | spa |
| dc.subject | Atención Primaria de Salud | spa |
| dc.subject.keywords | Renal Insufficiency,Chronic | eng |
| dc.subject.keywords | Quality of Health Care | eng |
| dc.subject.keywords | Quality Indicators, Health Care | eng |
| dc.subject.keywords | Primary Health Care | eng |
| dc.title | Factores impulsores y métodos de puntuación para mejorar el control de la enfermedad renal crónica en la atención primaria. Una propuesta peruana de modelo operativo | spa |
| dc.title.translated | Driving factors and scoring methods to improve chronic kidney disease control in primary care. A Peruvian proposal for an operating model | eng |
| dc.type.driver | info:eu-repo/semantics/article | |
| dc.type.spa | Artículo científico | |
| dcterms.references | Kalantar-Zadeh K, Jafar TH, Nitsch D, Neuen BL, Perkovic V. Chronic kidney disease. Lancet. 2021;398(10302):786-802. doi: 10.1016/ S0140-6736(21)00519-5. | eng |
| dcterms.references | Francis A, Harhay MN, Ong ACM, Tummalapalli SL, Ortiz A, Fogo AB, et al. Chronic kidney disease and the global public health agenda: an international consensus. Nat Rev Nephrol. 2024;20(7):473-485. doi: 10.1038/s41581-024-00820-6. | eng |
| dcterms.references | Ministerio de Salud de la Nación Argentina. Segundo Informe de Indicadores Priorizados [Internet]. Buenos Aires: Ministerio de Salud de la Nación; 2022 [citado el 10 de julio de 2025]. Disponible en: https://iah.msal.gov.ar/doc/902.pdf | spa |
| dcterms.references | GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709-733. doi: 10.1016/S0140-6736(20)30045-3. | eng |
| dcterms.references | Xie Y, Bowe B, Mokdad AH, Xian H, Yan Y, Li T, et al. Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int. 2018;94(3):567-581. doi: 10.1016/j. kint.2018.04.011. | eng |
| dcterms.references | Levin A, Ahmed SB, Carrero JJ, Foster B, Francis A, Hall RK, et al. Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns. Kidney Int. 2024;105(4):684-701. doi: 10.1016/j.kint.2023.10.016. | eng |
| dcterms.references | Thurlow JS, Joshi M, Yan G, Norris KC, Agodoa LY, Yuan CM, et al. Global Epidemiology of End-Stage Kidney Disease and Disparities in Kidney Replacement Therapy. Am J Nephrol. 2021;52(2):98-107. doi: 10.1159/000514550. | eng |
| dcterms.references | Bello AK, Okpechi IG, Levin A, Ye F, Damster S, Arruebo S, et al. An update on the global disparities in kidney disease burden and care across world countries and regions. Lancet Glob Health. 2024;12(3):e382-e395. doi: 10.1016/S2214-109X(23)00570-3. | eng |
| dcterms.references | Bello AK, Okpechi IG, Levin A, Ye F, Saad S, Zaidi D, et al. ISN–Global Kidney Health Atlas: A report by the International Society of Nephrology: An Assessment of Global Kidney Health Care Status focussing on Capacity, Availability, Accessibility, Affordability and Outcomes of Kidney Disease. Brussels, Belgium: International Society of Nephrology; 2023 [citado 9 octubre de 2025]. Disponible en: https://goo.su/D4e2 | eng |
| dcterms.references | Carrillo-Larco RM, Bernabé-Ortiz A. Mortalidad por enfermedad renal crónica en el Perú: tendencias nacionales 2003-2015. Rev Peru Med Exp Salud Publica. 2018;35(3):409-15. doi: 10.17843/ rpmesp.2018.353.3633. | spa |
| dcterms.references | Herrera-Añazco P, Benites-Zapata V, Hernandez AV, Mezones-Holguin E, Silveira-Chau M. Mortality in patients with chronic kidney disease undergoing hemodialysis in a public hospital of Peru. J Bras Nefrol. 2015;37(2):192-7. doi: 10.5935/0101-2800.20150031. | eng |
| dcterms.references | Campos C. Tercerización del Servicio de Hemodiálisis en ESSALUD y la rentabilidad del Centro de Diálisis CAVA SAC ubicado en Ate [Internet]. Lima: Universidad Peruana de Ciencias Aplicadas; 2017 [citado el 10 de julio de 2025]. Disponible en: https:// repositorioacademico.upc.edu.pe/bitstream/handle/10757/622806/ Campos_vc.pdf?sequence=5&isAllowed=y | spa |
| dcterms.references | Saldarriaga EM, Bravo-Zúñiga J, Hurtado-Roca Y, Suarez V. Costeffectiveness analysis of a strategy to delay progression to dialysis and death among chronic kidney disease patients in Lima, Peru. Cost Eff Resour Alloc. 2021;19(1):70. doi: 10.1186/s12962-021-00317-0. | eng |
| dcterms.references | Herrera-Añazco P, Benites-Zapata V, Diaz-Arocutipa C. Estrategias para el abordaje de la enfermedad renal crónica en el primer nivel de atención en Perú. Rev Cuerpo Med HNAAA. 2025;17(4):2782. doi: 10.35434/rcmhnaaa.2024.174.2782. | spa |
| dcterms.references | Ordunez P, Campbell NRC, DiPette DJ, Jaffe MG, Rosende A, Martínez R, et al. HEARTS en las Américas: impulsar el cambio en el sistema de salud para mejorar el control de la hipertensión en la población. Rev Panam Salud Publica. 2024;48:e17. doi: 10.26633/RPSP.2024.17. | spa |
| dcterms.references | Brettler JW, Giraldo GP, Aumala T, Best A, Campbell NRC, Cyr S, et al. Factores impulsores y métodos de puntuación para mejorar el control de la hipertensión en la práctica clínica de la atención primaria: recomendaciones del grupo de innovación de HEARTS en las Américas. Rev Panam Salud Publica. 2022;46:e56. doi: 10.26633/ RPSP.2022.56. | spa |
| dcterms.references | Calle MC, Depine SA, Hinojosa M, Mallqui M. Política andina de salud pública para enfrentar la enfermedad renal crónica [Internet]. Lima: Organismo Andino de Salud - Convenio Hipólito Unanue (ORAS CONHU); 2023 [citado el 10 de julio de 2025]. Disponible en: https:// acortar.link/d7pSUR | spa |
| dcterms.references | Chu CD, Xia F, Du Y, Singh R, Tuot DS, Lamprea-Montealegre JA, et al. Estimated Prevalence and Testing for Albuminuria in US Adults at Risk for Chronic Kidney Disease. JAMA Netw Open. 2023;6(7):e2326230. doi: 10.1001/jamanetworkopen.2023.26230. | eng |
| dcterms.references | George C, Echouffo-Tcheugui JB, Jaar BG, Okpechi IG, Kengne AP. The need for screening, early diagnosis, and prediction of chronic kidney disease in people with diabetes in low- and middleincome countries-a review of the current literature. BMC Med. 2022;20(1):247. doi: 10.1186/s12916-022-02438-6. | eng |
| dcterms.references | Herrera Añazco P, Bonilla Vargas L, Palacios Guillén M, Valencia Rodríguez J, Sánchez Riva F, Salomé Luna J, et al. Características clínicas de los pacientes diabéticos que acuden por primera vez a una consulta nefrológica en hospitales públicos de Lima. An Fac Med. 2014;75(1):25-29. | spa |
| dcterms.references | Bellido-Zapata A, Ruiz-Muggi JE, Neira-Sánchez ER, Málaga G. Implementación y aplicación de la “Guía de práctica clínica para el diagnóstico, tratamiento y control de la diabetes mellitus tipo 2 en el primer nivel de atención” en una red de establecimientos de salud públicos de Lima. Acta Med Peru. 2018;35(1):14-9. | spa |
| dcterms.references | Levin A, Ahmed SB, Carrero JJ, Foster B, Francis A, Hall RK, et al. Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns. Kidney Int. 2024;105(4):684-701. doi: 10.1016/j.kint.2023.10.016. | eng |
| dcterms.references | Writing Group for the CKD Prognosis Consortium. Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis. JAMA. 2023;330(13):1266- 1277. doi: 10.1001/jama.2023.17002. | eng |
| dcterms.references | Abidor E, Achkar M, Al Saidi I, Lather T, Jdaidani J, Agarwal A, et al. Comprehensive Review of Lipid Management in Chronic Kidney Disease and Hemodialysis Patients: Conventional Approaches, and Challenges for Cardiovascular Risk Reduction. J Clin Med. 2025;14(2):643. doi: 10.3390/jcm14020643. | eng |
| dcterms.references | Wanner C, Tonelli M. Kidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group Members. KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient. Kidney Int. 2014;85(6):1303-9. doi: 10.1038/ki.2014.31. | eng |
| dcterms.references | Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;74(10):1376-1414. doi: 10.1016/j.jacc.2019.03.009. | eng |
| dcterms.references | Vallejo-Vaz AJ, Bray S, Villa G, Brandts J, Kiru G, Murphy J, et al. DA VINCI Study Investigators. Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI. Cardiovasc Drugs Ther. 2023;37(5):941-953. doi: 10.1007/s10557-022-07343-x. | eng |
| dcterms.references | Calice-Silva V, Muenz D, Wong MMY, McCullough K, Charytan D, Reichel H, et al. CKDopps Investigators. International practice patterns of dyslipidemia management in patients with chronic kidney disease under nephrology care: is it time to review guideline recommendations? Lipids Health Dis. 2023;22(1):67. doi: 10.1186/ s12944-023-01833-z. | eng |
| dcterms.references | Bauer T, Gitt AK, Jünger C, Zahn R, Koeth O, Towae F, et al. Acute Coronary Syndromes Registry (ACOS) investigators. Guidelinerecommended secondary prevention drug therapy after acute myocardial infarction: predictors and outcomes of nonadherence. Eur J Cardiovasc Prev Rehabil. 2010;17(5):576-81. doi: 10.1097/ HJR.0b013e328338e5da. | eng |
| dcterms.references | Gaziano TA, Steyn K, Cohen DJ, Weinstein MC, Opie LH. Costeffectiveness analysis of hypertension guidelines in South Africa: absolute risk versus blood pressure level. Circulation. 2005;112(23):3569-76. doi: 10.1161/CIRCULATIONAHA.105.535922. | eng |
| dcterms.references | Delanaye P, Glassock RJ, De Broe ME. Epidemiology of chronic kidney disease: think (at least) twice! Clin Kidney J. 2017;10(3):370-374. doi: 10.1093/ckj/sfw154. | eng |
| dcterms.references | Mishima E, Haruna Y, Arima H. Renin-angiotensin system inhibitors in hypertensive adults with non-diabetic CKD with or without proteinuria: a systematic review and meta-analysis of randomized trials. Hypertens Res. 2019;42(4):469-482. doi: 10.1038/s41440- 018-0116-3. | eng |
| dcterms.references | Kuritzky L, Toto R, Van Buren P. Identification and management of albuminuria in the primary care setting. J Clin Hypertens (Greenwich). 2011;13(6):438-49. doi: 10.1111/j.1751-7176.2010.00424.x. | eng |
| dcterms.references | Tenorio-Mucha J, Lazo-Porras M, Hidalgo-Padilla L, Beran D, Ewen M. Precios, disponibilidad y asequibilidad de insulina en farmacias públicas y privadas en Perú. Rev Panam Salud Publica. 2019;43:e85. doi: 10.26633/RPSP.2019.85. | eng |
| dcterms.references | Andia Macavilca D. Análisis de la disponibilidad de medicamentos esenciales antihipertensivos en un Hospital III-1 de la Dirección de Redes Integradas de Salud (DIRIS) Lima Centro - Lima en el periodo de 2018 a 2021 [Internet]. Lima: Universidad Peruana Cayetano Heredia; 2023 [citado el 10 de julio de 2025]. Disponible en: https://goo.su/NsJeR | eng |
| dcterms.references | King S, Miani C, Exley J, Larkin J, Kirtley A, Payne RA. Impact of issuing longer- versus shorter-duration prescriptions: a systematic review. Br J Gen Pract. 2018;68(669):e286-e292. doi: 10.3399/bjgp18X695501. | eng |
| dcterms.references | Martin A, Payne R, Wilson EC. Long-Term Costs and Health Consequences of Issuing Shorter Duration Prescriptions for Patients with Chronic Health Conditions in the English NHS. Appl Health Econ Health Policy. 2018;16(3):317-330. doi: 10.1007/s40258-018-0383-9. | eng |
| dcterms.references | Gob.ar. [citado el 9 de octubre de 2025]. Disponible en: https:// goo.su/EDYrr | eng |
| dcterms.references | Campbell NRC, Ordunez P, DiPette DJ, Giraldo GP, Angell SY, Jaffe MG, et al. Monitoring and evaluation framework for hypertension programs. A collaboration between the Pan American Health Organization and World Hypertension League. J Clin Hypertens (Greenwich). 2018;20(6):984-990. doi: 10.1111/jch.13307. | eng |
| dcterms.references | Mendu ML, Waikar SS, Rao SK. Kidney disease population health management in the era of accountable care: a conceptual framework for optimizing care across the CKD spectrum. Am J Kidney Dis. 2017;70(1):122-131. doi: 10.1053/j.ajkd.2016.11.013. | eng |
| dcterms.references | Hynes DM, Fischer MJ, Schiffer LA, Gallardo R, Chukwudozie IB, Porter A, et al. Evaluating a novel health system intervention for chronic kidney disease care using the RE-AIM framework: Insights after two years. Contemp Clin Trials. 2017;52:20-26. doi: 10.1016/j. cct.2016.10.003. | eng |
| dcterms.references | Herrera-Añazco P, Atamari-Anahui N, Flores-Benites V. Número de nefrólogos, servicios de hemodiálisis y tendencia de la prevalencia de enfermedad renal crónica en el Ministerio de Salud de Perú. Rev Peru Med Exp Salud Publica. 2019;36(1):62-7. doi: 10.17843/ rpmesp.2019.361.4253. | spa |
| dcterms.references | Shlipak MG, Tummalapalli SL, Boulware LE, Grams ME, Ix JH, Jha V, et al. Conference Participants. The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2021;99(1):34-47. doi: 10.1016/j. kint.2020.10.012. | eng |
| dcterms.references | Llewellyn S. The chronic care model, kidney disease, and primary care: a scoping review. Nephrol Nurs J. 2019;46(3):301-328. | eng |
| oaire.version | info:eu-repo/semantics/publishedVersion |